What causes xp disease

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 4, 2026

Quick Answer: XP disease, or Xeroderma Pigmentosum, is a rare genetic disorder that prevents the body from repairing DNA damage caused by ultraviolet (UV) radiation. This inherited condition means individuals are extremely sensitive to sunlight and have a significantly increased risk of skin cancer.

Key Facts

XP disease is caused by mutations in genes responsible for DNA repair.
It is an autosomal recessive genetic disorder, meaning both parents must carry a copy of the altered gene.
Symptoms typically appear in infancy or early childhood, often with severe sunburn after minimal sun exposure.
Individuals with XP have a 10,000-fold increased risk of developing skin cancers.
There are approximately 1 to 10 cases per million people in the United States and Europe.

What is Xeroderma Pigmentosum (XP Disease)?

Xeroderma Pigmentosum (XP) is a rare, inherited disorder characterized by an extreme sensitivity to ultraviolet (UV) radiation, primarily from sunlight. This condition arises from defects in the DNA repair mechanisms of the body, specifically those that correct damage induced by UV light. Without proper repair, DNA mutations accumulate, leading to a dramatically increased risk of developing skin cancers and other related health issues.

Causes of XP Disease

The root cause of XP disease lies in genetics. It is an autosomal recessive disorder, meaning that an individual must inherit two copies of a mutated gene – one from each parent – to develop the condition. These mutations affect specific genes that are crucial for nucleotide excision repair (NER), a fundamental cellular process that fixes DNA damage. UV radiation, especially from the sun, causes specific types of DNA lesions, such as pyrimidine dimers. In individuals with XP, the cellular machinery responsible for recognizing and removing these dimers is faulty or absent. This leads to unrepaired DNA damage, which can cause mutations during DNA replication. Over time, these accumulated mutations can trigger the development of cancerous cells, particularly in the skin, but also potentially in other tissues.

Genetic Basis of XP

There are currently eight known genes associated with XP, designated as XP-A through XP-G and XP-V. Mutations in any of these genes can lead to the XP phenotype. For instance, mutations in genes like XPA, XPC, and XPG are involved in recognizing the DNA damage or in the excision of the damaged segment. The XP-V gene, however, encodes a translesion synthesis (TLS) DNA polymerase, which can bypass DNA lesions but is error-prone, leading to mutations. The specific gene mutated influences the severity of the condition and the degree of UV sensitivity.

Symptoms and Clinical Manifestations

The hallmark symptom of XP is extreme sensitivity to sunlight. Even brief exposure can cause severe sunburn, blistering, and freckling. This sensitivity typically manifests early in life, often by the age of two. Other common signs and symptoms include:

Early and frequent development of skin cancers (basal cell carcinoma, squamous cell carcinoma, and melanoma) at a young age.
Dry, scaly skin (xerosis).
Pigmentation abnormalities, such as irregular freckling and telangiectasias (small, dilated blood vessels).
Eye problems, including photophobia (light sensitivity), inflammation of the conjunctiva (conjunctivitis), and corneal damage.
Neurological abnormalities can occur in a subset of individuals with XP, particularly those with mutations in certain genes (e.g., XP-D, XP-G, XP-B). These can range from hearing loss and decreased reflexes to cognitive impairment and developmental delays.

Diagnosis and Management

Diagnosis of XP is typically based on clinical signs and symptoms, a history of severe sun sensitivity, and a family history of the disorder. Genetic testing can confirm the diagnosis and identify the specific gene mutation involved. Currently, there is no cure for XP disease. Management focuses on preventing UV exposure and early detection and treatment of skin cancers. This includes:

Strict avoidance of sunlight, especially during peak hours.
Wearing protective clothing, wide-brimmed hats, and UV-blocking sunglasses.
Using broad-spectrum sunscreen with a high SPF.
Regular dermatological examinations to monitor for skin changes and detect cancers early.
Protection of the eyes from UV light.
For neurological symptoms, supportive care and management of specific issues are provided.

Research is ongoing to develop potential gene therapies and other innovative treatments to improve DNA repair capabilities in affected individuals.

Prognosis

The prognosis for individuals with XP varies depending on the specific gene mutation, the severity of symptoms, and the effectiveness of preventative measures and cancer management. Without strict protection from UV radiation and regular medical care, the risk of premature death due to skin cancer or other complications is high. However, with diligent adherence to protective measures and early cancer treatment, individuals can live longer, albeit with ongoing challenges.